| Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin O Kovalchuk, J Filkowski, J Meservy, Y Ilnytskyy, VP Tryndyak, ... Molecular cancer therapeutics 7 (7), 2152-2159, 2008 | 808 | 2008 |
| Иммунология злокачественного роста НМ Бережная, ВФ Чехун Наукова думка, 2005 | 262 | 2005 |
| Role of ferritin alterations in human breast cancer cells SI Shpyleva, VP Tryndyak, O Kovalchuk, A Starlard-Davenport, ... Breast cancer research and treatment 126, 63-71, 2011 | 234 | 2011 |
| MicroRNA-mediated drug resistance in breast cancer KR Kutanzi, OV Yurchenko, FA Beland, VF Checkhun, IP Pogribny Clinical epigenetics 2, 171-185, 2011 | 197 | 2011 |
| Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper-and hypomethylated targets VF Chekhun, NY Lukyanova, O Kovalchuk, VP Tryndyak, IP Pogribny Molecular cancer therapeutics 6 (3), 1089-1098, 2007 | 152 | 2007 |
| Система интерлейкинов и рак НМ Бережная, ВФ Чехун Киев: Диа, 2000 | 144 | 2000 |
| Long-term exposure to microwave radiation provokes cancer growth: evidences from radars and mobile communication systems I Yakymenko, E Sidorik, S Kyrylenko, V Chekhun | 114 | 2011 |
| Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells VF Chekhun, GI Kulik, OV Yurchenko, VP Tryndyak, IN Todor, LS Luniv, ... Cancer letters 231 (1), 87-93, 2006 | 106 | 2006 |
| Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin VF Chekhun, NY Lukyanova, АP Burlaka, NA Bezdenezhnykh, ... International journal of oncology 43 (5), 1481-1486, 2013 | 102 | 2013 |
| Synthesis and antiproliferative activity of conformationally restricted 1, 2, 3-triazole analogues of combretastatins in the sea urchin embryo model and against human cancer … DV Demchuk, AV Samet, NB Chernysheva, VI Ushkarov, GA Stashina, ... Bioorganic & medicinal chemistry 22 (2), 738-755, 2014 | 83 | 2014 |
| Improved Synthesis of N-Benzylaminoferrocene-Based Prodrugs and Evaluation of Their Toxicity and Antileukemic Activity S Daum, VF Chekhun, IN Todor, NY Lukianova, YV Shvets, L Sellner, ... Journal of medicinal chemistry 58 (4), 2015-2024, 2015 | 81 | 2015 |
| Эозинофилы, базофилы и иммуноглобулин Е в противоопухолевой защите НМ Бережная, ВФ Чехун, РИ Сепиашвили Аллергология и иммунология 6 (1), 38-49, 2005 | 81 | 2005 |
| Molecular profile and cell cycle in MCF-7 cells resistant to cisplatin and doxorubicin NY Lukyanova, NV Rusetskya, NA Tregubova, VF Chekhun Experimental oncology, 2009 | 80 | 2009 |
| The lipid content of cisplatin-and doxorubicin-resistant MCF-7 human breast cancer cells IN Todor, NY Lukianova, VF Chekhun Experimental oncology, 2012 | 78 | 2012 |
| Роль генов р53 и bcl-2 в апоптозе и лекарственной резистентности опухолей НЮ Лукьянова, ГИ Кулик, ВФ Чехун Вопр. онкол 46 (2), 121-128, 2000 | 70 | 2000 |
| Nanohyperthermia of malignant tumors. I. Lanthanum-strontium manganite magnetic fluid as potential inducer of tumor hyperthermia S Solopan, A Belous, A Yelenich, L Bubnovskaya, A Kovelskaya, ... Experimental Oncology, 2011 | 66 | 2011 |
| Expression of CD40 and CD40L on tumor cells: the role of their interaction and new approach to immunotherapy NM Bereznaya, VF Chekhun Experimental oncology, 2007 | 51 | 2007 |
| MicroRNAs in normal and cancer cells: a new class of gene expression regulators TV Bagnyukova, IP Pogribny, VF Chekhun Інститут експериментальної патології, онкології і радіобіології ім. РЄ …, 2006 | 51 | 2006 |
| СD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes SV Chekhun, TV Zadvorny, YO Tymovska, MF Anikusko, OE Novak, ... Experimental oncology, 58-63, 2015 | 46 | 2015 |
| Immunology of malignant growth NM Berezhnaya, VF Chekhun Kyiv: Naukova Dumka, 2005 | 41 | 2005 |
